@article{10681b4f0a144e9da93454fcc4aec2b7,
title = "Infusion-related hypersensitivity reactions during natalizumab treatment",
author = "Phillips, {J. T.} and O'Connor, {P. W.} and E. Havrdova and M. Hutchinson and L. Kappos and Miller, {D. H.} and Polman, {C. H.} and Lublin, {F. D.} and G. Giovannoni and A. Wajgt and F. Lynn and Panzara, {M. A.} and Sandrock, {A. W.}",
note = "Funding Information: Disclosure: The AFFIRM study was sponsored by Biogen Idec and Elan Pharmaceuticals. Dr. Phillips reports having received grant support ($10,000) from Biogen Idec for other research or activities not reported in this article, as well as honoraria ($10,000) from Biogen Idec for other research or activities not reported in this article and honoraria ($10,000) from Biogen Idec for other research or activities not reported in this article. Dr. Lublin reports having received honoraria (>$10,000) from Biogen Idec during the course of this study. Ms. Lynn, Dr. Panzara, and Dr. Sandrock have equity interests (>$10,000) and are employees of Biogen Idec. Dr. Wajgt has reported no conflicts of interest. ",
year = "2006",
month = nov,
doi = "10.1212/01.wnl.0000242629.66372.33",
language = "English",
volume = "67",
pages = "1717--1718",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "9",
}